[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 30, 1971

Hemolytic Anemia Associated With Cephalothin

Author Affiliations

From the Hematology Service (Dr. Gralnick) and Blood Bank (Miss McGinniss), Clinical Center, National Institutes of Health, Bethesda, Md; Cowlitz Hospital, Longview, Wash (Dr. Elton); and the Hematology Division, Georgetown University, District of Columbia General Hospital, Washington, DC (Dr. McCurdy).

JAMA. 1971;217(9):1193-1197. doi:10.1001/jama.1971.03190090015004

Two patients developed Coombs' positive hemolytic anemia while receiving cephalothin sodium therapy. An anticephalothin antibody was detected in the IgG fraction of sera and in the red blood cell (RBC) eluates in both patients. This complication of cephalothin therapy is rare, and must be differentiated from the positive Coombs' reaction seen in the majority of patients receiving cephalothin. In any patient receiving cephalothin, unexplained hemolysis must include a search for anticephalothin and antipenicillin antibodies on the RBC before the drug can be implicated in any hemolytic episode.